Security key
71535D106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 84,584,420
- Total 13F value
- $538,766,511
- Share change
- +3,324,074
- Put/Call ratio
- 86%
- SEC-reported price per share
- $6.37
- Number of holders
- 138
- Value change
- +$18,994,611
- Number of buys
- 75
- Number of sells
- 55
- Shares outstanding
- 104,571,678
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
138
Top holders
10
PSNL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Personalis, Inc. SEC filings
Personalis, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71535D106
Recent filing periods:
Ownership snapshot
Top reported holders of PSNL - Personalis, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Merck & Co., Inc.
Disclosed value leader
Tempus AI, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F
13D/G
3/4/5
Lead comparable stake: 16%
13D/G row: Merck & Co., Inc.
Showing 1-6 of 15 holder rows.
Quick read
Merck & Co., Inc. leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Merck & Co., Inc.'s linked filing trail.
Comparable ownership
Top 5
Merck & Co., Inc.
16%
ARK Investment Management LLC
8.1%
AMERIPRISE FINANCIAL INC
7.1%
T. Rowe Price Investment Manageme...
4.5%
Orin Hirschman
3.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Merck & Co., Inc. |
13F
13D/G
3/4/5
Company · 10%+ Owner
|
16%
from 13D/G
|
$111,797,746
14,044,943 shares
|
— | 31 Dec 2025 |
| ARK Investment Management LLC |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$62,717,533
7,879,087 shares
|
— | 31 Dec 2025 |
| AMERIPRISE FINANCIAL INC |
13D/G
13F
Company
|
7.1%
|
$53,880,884
6,287,151 shares
|
$0 | 31 Dec 2025 |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
Company
|
4.5%
from 13D/G
|
$85,812,000
10,780,290 shares
|
— | 31 Dec 2025 |
| Orin Hirschman |
13D/G
|
3.8%
|
$27,205,633
3,416,720 shares
|
-$6,982,468 | 31 Dec 2025 |
| Tempus AI, Inc. |
3/4/5
10%+ Owner
|
12%
|
$116,438,868
13,039,067 shares
|
+$2,739,181 | 18 Nov 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
138
Shares
84,584,420
Rows available
138
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
138
Q1 2026 holders
138
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend